Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I registered for that presentation alright.
Presume Amryt will email a link?
Has opened a new position here and AMYT has jumped to the top of the most followed companies on V o x Markets.
May, therefore , generate some new buying (as it should. I rate Paul highly after previous tips)
He reckons on a SP of £2:40 to £5 over the coming years
6:30 minutes into the following: https://youtu.be/fb16Yg6XiD8
Will be tuning into the Capital Markets day tomorrow at 3:00pm https://lifesci.rampard.com/WebcastingAppv5/Events/eventsDispatcher.jsp?Y2lk=MTM1Mw==
No.
Anyone got any idea why we're falling here?
Thank you.
There are no reported short positions.
Is this getting shorted?
Some large trades going on in black?
Bothwell, Historically, this one has always risen slowly - no change in that momentum unless a groundbreaking RNS appears; but, it will probably continue its slow upwards push in anticipation of greeting the FDA approval.
Another move in the right direction.
We should be sitting at over 200.00 at this moment in time.
SVB Leerink and Cowen have both initiated coverage of AMYT with $22 target
I have been here for some time and the performance pattern of this share when compared to past performance does indicate that there is significant upside, the pipeline of development products substantiates this view .
Amryt nearly 9% up on Nasdaq?
Exciting run-up to Christmas: Chiasma integration and FDA approval for Oleogel - two huge value-enhancing events.
I have seen this pattern here before. It does again look as if there is something going on behind the scenes and if it is success it will be very positive
Some nice buys today. On the move upwards soon.
I was scrambling yesterday to get fully in under 1.60...I thought it was going to go 1.30's..
Looks like a change in sentiment here..
Not sure whether this has already been posted elsewhere but Amati fund manager, Dr Paul Jourdan talks about his portfolio in the link below and discusses Amryt at about 37.50 - well worth a listen
https://www.youtube.com/watch?v=eYObwUdaKpE
Thanks Bermuda..just updating this forum
bermudashorts: I assume he's referring to the TR1 yesterday showing Athyrium's % holdings falling from 24% to 14% but as you have pointed out, this is simply a reflection of the additional shares in issue following the Chiasma acquisition. Their holding has actually remained the same. The reason for the downturn over recent months is highly likely to be down to the distribution of over 2m AMYT ADRs by Novelion's liquidator back in March. Hopefully that's all washed through now and we'll see a good recovery into news due in H2. IMO etc.
joxer22 - interesting thanks.
There was quite a bit of news during Q2, including the announcement of the proposed acquisition of Chiasma and news around the submission of the NDA for AP101 to the FDA. 13f SEC filings for Q2 are due in a few days - will be interesting to see any changes in institutional holdings during the period.
Bronxville,
Yes thanks for that - confirms my posts on Friday.
The last few paragraphs list some recent transactions in AMYT by various institutional investors:
https://www.americanbankingnews.com/2021/08/09/amryt-pharma-nasdaqamyt-earns-buy-rating-from-hc-wainwright.html